ImaginAb Competitors and Similar CompaniesClear all
ImaginAb's competitors and similar companies include ImmusanT.
 ImaginAb ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins. |  ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. | |
Founding Date | Founding Date 2007 | Founding Date 2010 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Inglewood, US HQ Bracknell, GB | Locations Cambridge, US HQ |
Employees | Employees 195% decrease | Employees 2 |
Funding | ||
Total funding raised | Total funding raised $ 46.8m | Total funding raised $ 72.8m |
For sources of this data, please see the company profile
View Company Profiles
ImmusanT
HQ
Cambridge, US
Employees
2
ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
View company